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A Femtosecond Laser Creates a Stronger Flap than a
Mechanical Microkeratome
Jae Yong Kim, Myoung Joon Kim, Tae-im Kim, Hyun-jeung Choi, Jhang Ho Pak, and
Hungwon Tchah
PURPOSE. To compare corneal flaps made with a femtosecond
(FS) laser with those made with a mechanical microkeratome
(MM) in rabbits, measuring early postoperative inflammation
and apoptosis and late postoperative adhesion strength.
METHODS. Study 1 involved four treatment groups: one with
flaps made only with the FS laser (FS group), one with flaps
made with the FS laser followed by excimer laser ablation
(FSLASIK), one with flaps made with the MM, and one with
flaps made with the MM followed by excimer laser ablation
(MMLASIK). The eyes were analyzed by histology and TUNEL
staining for apoptosis at 4 and 24 hours. Study 2 involved two
reference groups: an FS group and an MM group. Adhesion
strength was measured with a tension meter 1 and 3 months
later.
RESULTS. Study 1: Inflammatory cell infiltration in the central
cornea was significantly greater in the FS group than in the MM
group at 4 and 24 hours (P  0.05) and was significantly
greater in the FSLASIK group than in the MMLASIK group
at 24 hours (P  0.05). Infiltration at the peripheral interface
was significantly greater in the FS group than in the MM group
and was significantly greater in the FSLASIK group than in
the MMLASIK group at 24 hours (P 0.05). Study 2: At 1 and
3 months, 126.7 and 191.3 grams of force (gf) were needed to
detach the flaps in the FS group, compared with 65 and 127.5
gf in the MM group, respectively. The grams of force needed
was significantly higher in the FS group than in the MM group
at 3 months (P  0.05).
CONCLUSIONS. The FS laser produces greater corneal stromal
inflammation than the MM early postoperatively without any
increase in apoptosis and stronger flap adhesion late postop-
eratively. Therefore, it may require stronger anti-inflammatory
drugs to be administered. (Invest Ophthalmol Vis Sci. 2006;47:
599–604) DOI:10.1167/iovs.05-0458
The corneal wound-healing response after refractive surgeryis extremely complex. Apoptotic keratocytes and inflam-
matory cell infiltrations are the earliest changes noted in the
cornea when there is injury to the epithelium.1–3 Apoptosis is
delayed and detected to be at its maximum at 4 hours after
injury, when assayed with terminal deoxyribonucleotide trans-
ferase-mediated duTP-digoxigenin nick end labeling (TUNEL).4
The remaining keratocytes surrounding the apoptotic zone and
begin to undergo proliferation within 12 to 24 hours (Hutch-
eon SR et al. IOVS 1999;40:ARVO E-Abstract 622). These pro-
liferating cells give rise to wound-healing keratocyte-derived
cells called myofibroblasts.5,6 Cytokines produced by myofi-
broblasts, such as fibroblast growth factor (FGF), keratocyte
growth factor (KGF), and transforming growth factor (TGF)-,
regulate the proliferation, migration, and differentiation of the
overlying healing epithelium.7,8 Polymorphonuclear leuko-
cytes (PMNs) are the first cells to migrate into the corneal
tissues in response to injury. They are highly differentiated
cells that are unable to proliferate9 and are found in the limbus
and wounded areas within the first 2 days after corneal injuries
such as superficial epithelial defects and alkaline burns.10,11
The density of PMNs starts to decline by the third day, and
other cell types, such as mononuclear phagocytes appear along
with signs of new capillaries.12
Apoptosis in keratocytes and inflammatory cell infiltrations
occur immediately beneath the healing epithelium after pho-
torefractive keratectomy (PRK). These phenomena occur at
the level of the interface, further from the overlying epithe-
lium, after laser-assisted in situ keratomileusis (LASIK). Epithe-
lial hyperplasia appears to be lower after LASIK than PRK, even
though epithelial hyperplasia can occur after LASIK.13 As epi-
thelium-derived cytokines appear to be the inducers of kerato-
cyte apoptosis, the surgeon should seek to minimize the intro-
duction of epithelial tissue into the interface. Even though
LASIK is best performed with sharp blades that incise the
epithelium with minimal trauma, a femtosecond (FS) laser
(e.g., the IntraLase FS; IntraLase, Irvine, CA) laser could be
more useful in producing a flap with uniform thickness and
minimal introduction of epithelial debris and cytokines into the
interface.14
In vitro studies using cultures of human corneal fibroblasts
have shown that TGF and epidermal growth factor (EGF)
both stimulate the chemotaxis of corneal fibroblasts, and EGF
enhances DNA synthesis.15,16 They also increase the synthesis
of collagen and fibronectin. Treatments with these growth
factors probably increase the tensile strength of corneal inci-
sions by influencing key processes of scar formation: increas-
ing the chemotactic migration of corneal fibroblasts to the site
of a stromal injury, increasing mitosis of fibroblasts, and stim-
ulating synthesis of collagen. During corneal wound healing
after LASIK, various cytokines, including TGF and epidermal
growth factor (EGF), are released into the interface. These
factors may affect the adhesive strength of flaps made by
different keratomes. Therefore, it has been postulated that
flaps created with FS lasers may show less inflammatory cell
infiltration and apoptosis because of improved epithelial pres-
ervation at the early postoperative period and may have
weaker adhesion strength during the late postoperative period
than those created with a mechanical microkeratome (MM).14
The goals of this study were to compare the effects of an FS
laser and an MM on corneal wound healing in an animal model.
We determined inflammatory cell infiltration and apoptosis
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around corneal flaps at the early postoperative period and the
adhesion strength of flaps at the late postoperative period. To
our knowledge, this is the first study using an animal model to
compare these methods.
METHODS
Materials
Fetal bovine serum (FBS), Dulbecco’s modified Eagle’s medium
(DMEM), Hanks’ balanced salt solution (HBSS), phosphate-buffered
saline (PBS), trypsin-EDTA, and penicillin-streptomycin were pur-
chased from Invitrogen-Life Technologies (Gaithersburg, MD); the
TUNEL staining kit from Roche Molecular Biochemicals (Mannheim,
Germany); and all chemicals (biotechnology grade) from Amresco
(Solon, OH).
Study 1: Procedures
The first study involved four reference groups: one (FS group, n  12)
with flaps made with an FS laser (IntraLase Corp.); one (FSLASIK
group, n  12) with flaps made with an FS laser followed by excimer
laser ablation; one (MM group, n  12) with flaps made with an
automated corneal shaper (ACS; Bausch & Lomb, Rochester, NY); one
(MMLASIK group, n  12) with flaps made with an MM followed by
excimer laser ablation; and a control group (n  12) in which no
procedure was performed. Untreated left eyes of rabbits randomly
assigned four to a group were used as the control.
Animals and Preparation. Procedures were conducted in
conformity with the ARVO Statement for the Use of Animals in Oph-
thalmic and Vision Research. New Zealand albino rabbits weighing 1.5
to 2 kg were used. Each rabbit was anesthetized intramuscularly with
xylazine hydrochloride (10 mg/kg) and ketamine hydrochloride (50
mg/kg) and received 0.5% proparacaine hydrochloride topical eye
drops (Alcon-Couvreur, Puurs, Belgium) with 0.1% levofloxacin
(Santen Pharmaceutical Co., Osaka, Japan). Each right eye was prop-
tosed anterior to the eyelids and temporarily retained in that confor-
mation by clamping the temporal upper and lower eyelids together
with a mosquito clamp.
FS Laser Procedure. An FS laser was used to make a flap in the
FS and FSLASIK groups. We attempted to hold the anesthetized
rabbit’s head still and a flat, glass contact lens was used to applanate
the cornea without using a suction ring. The initial settings were a
planned flap diameter of 8.0 mm, a flap thickness of 110 m, a hinge
angle of 50°, a flap energy of 3.2 J, a beam separation of 10  11 m,
and a side-cut energy of 3.2 J. After the cornea had been applanated
with the disposable glass lens, a contact lens cone attached to the FS
laser was lowered into position over the eye. When the settings were
acceptable, the laser was activated, and the ablation began from the
hinge in a raster pattern, moving horizontally. The hinge location was
superior in all cases. After waiting 5 minutes to allow the absorption of
microcavitation bubbles, we used a spatula to separate the flap by
breaking microadhesions in the laser wound in the temporal quadrant
near the hinge. The spatula was wiped free of epithelium, placed in the
initial location, advanced 3.0 mm, and swept inferiorly. The interface
was opened in one to three such passes, and the flap was then
reflected superiorly. One drop of 0.1% levofloxacin was placed in the
interface, and the flap was repositioned using the spatula. Three 10-0
nylon sutures were used to inhibit detachment of the flap at the nasal,
temporal, and inferior interfaces. After the mosquito clamp was re-
moved from the eyelid, tarsorrhaphy was performed in each treated
eye and continued for the first 4 and 24 hours.
Mechanical Microkeratotomy. In the MM and MMLASIK
groups, a microkeratome (ACS; Bausch & Lomb) was used to make a
flap. A corneal flap (130 m thick) was made with a nasal hinge
position in the right eye of all rabbits, by using the ACS microkeratome
without a suction ring. A new blade was used for each rabbit. A spatula
was used to free the laser wound in the temporal quadrant near the
hinge. One drop of 0.1% levofloxacin was placed in the interface, and
the flap was repositioned with the spatula. The remaining procedures
were as described for the laser method.
Excimer Laser Ablation. In the FSLASIK and MMLASIK
groups, after a flap was created, excimer laser ablation was performed
(Zyoptix 217z laser; Bausch & Lomb) at 10 Hz with a 5.0-mm optical
zone. The intended correction was10 D. After ablation, the interface
was cleaned with a dry cellulose sponge. One drop of 0.1% levofloxa-
cin was placed in the interface, and the flap was repositioned with a
spatula. The remaining procedures were the same as for the FS laser
ablation.
Tissue Processing and Analysis. The rabbits were euthana-
tized by CO2 inhalation at 4 and 24 hours after the procedures. Eyes
were immediately enucleated and fixed in 4% paraformaldehyde for 24
hours. The corneas were excised, bisected, embedded in paraffin wax,
and sectioned at 5 m. Sections were subjected to hematoxylin and
eosin (H&E) staining and TUNEL assay. After H&E staining, the num-
bers of inflammatory cells in the corneal stroma around the flap were
counted in three fields of three tissue slides for each specimen under
a phase-contrast microscope (Olympus, Tokyo, Japan). Counting was
performed at the central cornea and peripheral interface. To eliminate
any possible investigator bias, this procedure was performed in a
blinded fashion on serially numbered slides.
TUNEL Assay. To evaluate the degree of apoptosis, we per-
formed a TUNEL assay with a fluorescence apoptosis detection system,
according to the manufacturer’s instructions (Roche). Four sections
from each specimen were evaluated with an inverted microscope
(DMIRE2; Leica, Deerfield, IL) equipped with a confocal laser scanning
system (TSC-SP2; Leica, Heidelberg, Germany) at high magnification
(400) to count TUNEL-positive keratocytes around the flap.
Study 2: Measurement of Adhesion Strength
The second study used two groups of rabbits: the FS group with flaps
made with an FS laser (n 8), and the MM group with flaps made with
an MM (n  8). Corneal flaps were made as just described. One drop
of 0.1% levofloxacin was placed in the interface, and the flap was
repositioned with a spatula. The remaining procedures were as de-
scribed.
Measurement of Adhesion Strength. Rabbits were euthana-
tized by CO2 inhalation at 1 and 3 months after the procedures. We
located the edge of the flap with a microscope and separated enough
of it with a curved mosquito clamp to permit the attachment of a 6-0
black silk loop suture, also gripped by a mosquito clamp. The length of
the loop suture was 10 cm. A tension meter (Attonic, Aichi, Japan) was
used to measure the adhesion strength, and flap movement was ob-
served by microscope. When the loop suture was pulled with a con-
tinuous load, the center of the flap lifted, and the edge of the flap
started to slip. Finally, the entire flap became detached from the
corneal bed. The load at flap detachment was measured, and the values
were compared between groups.
Statistical Analyses
Data are expressed as the mean  SE. Statistical comparisons of
inflammatory cell and number of apoptotic cells were performed with
Student’s t-tests and ANOVA. Adhesion strengths were analyzed with
nonparametric Mann-Whitney tests. The level of significance was taken
as P  0.05.
RESULTS
Study 1: Histologic Findings
At the central cornea, the number of inflammatory cells was
significantly greater than in the control in all groups at 4 and 24
hours, except in the FSLASIK group at 4 hours and in the
MMLAISK group at 24 hours (Table 1; Figs. 1, 2, 3; P 0.05).
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Infiltration at the peripheral interface was also significantly
greater than controls in all groups (P  0.05).
At 4 hours, inflammatory cell infiltration at the central
cornea was significantly greater in the FS group than in the MM
group (P  0.05). It was also significantly greater in the FS
group than in the FSLASIK group at 4 hours (P 0.05). At 24
hours, infiltration at the central cornea was significantly greater
in the FS group than in the MM group, in the FSLASIK group
than in the MMLAISK group and in the FS group than in the
FSLASIK group (P  0.05). At 24 hours, infiltration at the
peripheral interface was significantly greater in the FS group
than in the MM group, in the FSLASIK group than in the
MMLASIK group, in the FS group than in the FSLASIK
group, and in the MM group than in the MMLASIK group
(P  0.05).
Evaluation of Apoptosis. There were significantly more
apoptotic cells in the central cornea in every group at 4 and 24
hours than in the control (Table 2; Figs. 1, 2, 4. P  0.05).
There were no statistically significant differences between
groups, except that there were significantly more apoptotic
cells in the FS group than in the FSLASIK group at 4 hours
(P  0.05).
Study 2: Adhesion Strength
In the FS group, 126.7 and 191.3 g of force (gf) were needed
to separate the flap at 1 and 3 months after the procedure,
respectively; in the MM group the corresponding values were
65 and 127.5 gf (Fig. 5). The adhesion strength increased
marginally over time in both groups (P  0.09 and 0.11 in the
FS and MM groups, respectively). The adhesion strength in the
FS group was marginally higher than in the MM group at 1
month (P 0.1), but was significantly higher at 3 months (P
0.05).
DISCUSSION
FS lasers provide potentially safe advantages over the MM
approaches, because they cut flaps with uniform thickness.
These avoid the central thinning and entrance hinge disparity
associated with blade cutting.14 Moreover, flap size and thick-
ness, edge angle, hinge width, and locations are easily varied.14
The flap diameter and hinge size and location are more pre-
dictable than those with microkeratomes, for which the stan-
dard deviation of the flap diameter is 0.3 mm.17 Suction rings
and applanation glasses are disposable for the FS laser, possibly
decreasing contamination and saving time used for steriliza-
tion. Above all, improved epithelial preservation is a significant
safety advantage for the FS laser.14
The disadvantages of an FS laser are that the surface of
stromal bed created with the FS laser was not as smooth as that
produced with an MM.18 Also, it was recently demonstrated by
scanning electron microscopy (SEM) that surface irregularity
was greater in the bed of lamellar keratotomies created with FS
lasers than in those created with MMs.19 Two slipped flaps and
20 cases of interface inflammation were reported in a series
that included 103 eyes.20 One case of macular hemorrhage
after LASIK with an FS laser flap creation has been reported.21
It has been postulated that corneal flaps created by FS lasers
could produce less corneal stromal inflammation and apoptosis
in the early postoperative period because of improved epithe-
lial preservation and that they might have weaker adhesion
FIGURE 2. Quantitation of inflammatory cells in central cornea and
peripheral interface and TUNEL-positive cells in the central cornea at
24 hours. Error bars, SEM. ***, **, * Significant differences between
those groups at a particular time (P  0.05).
TABLE 1. The Number of Inflammatory Cells around the Corneal Flap
Area
Time
(h)
Groups
Control FS FS  LASIK MM MM  LASIK
Central cornea 4 0  0 11.4  3.0** 1.5  0.9* 3.4  1.5* 2.7  0.7*
24 0  0 27.8  2.8*** 11.7  2.1** 6.0  1.2* 2.2  1.0*
Peripheral interface 4 0  0 49.4  3.4 42.2  2.3 39.8  4.6 40.3  4.9
24 0  0 80.5  5.8*** 47.7  3.9** 38.5  5.2** 26.6  2.4*
Data are expressed as mean cells per 400 field  standard error.
***, **, * Significant differences between those groups at a particular time (P  0.05).
FIGURE 1. Quantitation of inflammatory cells in the central cornea
and peripheral interface and TUNEL-positive cells in the central cornea
at 4 hours. Error bars, SEM. ***, **, * Significant differences between
those groups at a particular time (P  0.05).
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strength than those created with MMs in the late postoperative
period.14 Our results were completely inconsistent with both
of these ideas. In the early postoperative period, there was
more corneal stromal inflammation in the FS and FSLASIK
groups. Such inflammatory cell infiltration into injured corneal
tissue is a hallmark of wound repair.22,23 PMNs are the first
cells to migrate into the tissue in response to injury and may
enter the wound, phagocytose bacteria, secrete proteases that
remove damaged extracellular matrix components, and release
cytokines and growth factors. The macrophages produce
FGF, TGF, platelet-derived growth factor (PDGF), and insu-
lin-like growth factor (IGF).10,11 PMNs also produce TGF1,
which stimulates the proliferation of keratocytes and other
factors that in turn attract macrophages to the area.9 Depletion
of leukocytes markedly delays fibroblast proliferation,24 sug-
gesting the importance of these factors. Therefore, leukocytes
are potent sources of growth factors and cytokines, all of
which are necessary for the initiation and propagation of new
tissue formation in wounds.25
Excessive inflammatory cell infiltration or diffuse lamellar
keratitis (DLK) is probably attributable to endogenous factors
that trigger inflammation, mainly secondary to epithelial injury
after LASIK.26 Although the etiology of DLK is unknown, sev-
eral reports have linked epithelial defects, trauma, Meibomian
gland secretions, and bacterial toxins with DLK.27 The genesis
of DLK can be associated with the release of proinflammatory
cytokines from the corneal epithelium and flap interface. A
platelet-activating-factor receptor antagonist was reported to
block both the induction of DLK and keratocyte apoptosis.28
The severity of gutter in the corneal flap margin was also
associated with the incidence of DLK.29 As mentioned earlier,
Solomon et al.19 used SEM to show that surface irregularity was
greater in the beds of lamellar keratectomies created with an FS
laser than those created with an MM. Because the flap edge
created with an FS laser can be deeply cut or irregular, re-
epithelialization may take more time, and more inflammatory
cells may infiltrate in the flap interface than with an MM. In
contrast, Binder20 described 20 cases of interface inflammation
(DLK) in which there was no effect on visual outcome after
LASIK with an FS laser.20 Decreases in the side-cut energy and
side-cut angle eliminated the interface inflammation. In that
series, a side-cut energy of 6 to 8 J, which was considerably
higher than the 3.2 J used in our study, was applied. Although
it was difficult to compare the data from both studies directly,
because different experimental subjects were involved, the
side-cut energy could be related to inflammatory cell infiltra-
FIGURE 4. Detection of apoptosis
by TUNEL assay in the central cornea
of each group at 4 and 24 hours. The
TUNEL-positive cells were scattered
in the areas near the lamellar inter-
face created by the keratotomy.
There were no statistically significant
differences between groups, except
that there were significantly more ap-
optotic cells in the FS group than in
the FSLASIK group at 4 hours (P 
0.05, cells/400 field).
FIGURE 3. The inflammatory cell in-
filtration of central cornea observed by
phase contrast microscopy. At 4 and
24 hours, inflammatory cell infiltration
was significantly greater in the FS
group than in the MM group (P 
0.05). At 24 hours, infiltration was sig-
nificantly greater in the FSLASIK
group than in the MMLASIK group
(P  0.05, cells/400 field).
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tion in the FS group. Furthermore, the higher energy of an FS
laser than that of an MM could explain the more inflammatory
cell infiltration in the corneal stoma in the FS group in this
study. Using a lower side-cut energy can alleviate such inflam-
matory cell infiltration.20 In particular, we found prominent
inflammatory cell infiltration after FS laser LASIK using this
animal model. Thus, after a flap is created with an FS laser,
stronger anti-inflammatory drugs may to be necessary to con-
trol postoperative inflammation.
It was also significant that the flaps made with an FS laser
showed higher adhesion strengths than those created with an
MM: the first such report to our knowledge. In this study, flap
creation with an FS laser caused more inflammatory cell infil-
tration of the corneal stroma at early postoperative period. This
is likely to increase flap adhesion strength later, because leu-
kocytes are a source of growth factors and cytokines, all of
which are necessary for initiation and propagation of new
tissue formation in wounds.25 Further studies are needed to
prove such a relationship. Furthermore, when surgeons per-
form enhancement after LASIK, the required flap can be pro-
duced by either recutting or lifting the previous flap. Flap
lifting is very easy, even several months after the first LASIK.
Every surgeon experiences some cases of accidental self-re-
moval of a flap or flap dislocation caused by trauma, even long
after LASIK. Therefore, the widespread use of FS lasers could
make stronger flaps that are more resistant to trauma and
reduce the incidence of such a disastrous complication, but
such flaps cannot be lifted easily if later corneal enhancement
is needed.
It was noteworthy that inflammatory cell infiltration and
apoptosis of the corneal stroma were more severe in the
groups where only a flap was created than in the groups where
laser ablation was performed after the creation of a flap with
both FS laser and MM. This finding contrasts with that of a
previous study.30 In that study, hinged corneal flaps created
with an ACS MM (Bausch & Lomb) and repositioned without
any laser treatment had a lower rate of apoptosis than in the
LASIK group where a hinged corneal flap was created and
treated by laser ablation (5 D). We suspect this discrepancy
may be attributable to the different experimental settings: the
higher-energy laser ablation used in this study with the goal of
correcting high myopia (10 D) probably removed more epi-
thelial debris, cytokines from injured epithelium, and their
receptors of keratocytes posterior to the interface than did the
low-energy laser ablation used in previous study. In addition,
the TUNEL-positive cells were scattered in the areas anterior
and posterior to the lamellar interface in the FS and MM
groups. Conversely, in the FSLASIK and MMLASIK groups,
these cells were scattered in the areas only anterior to the
lamellar interface, which meant that most cytokine receptors
in keratocytes posterior to the interface were removed by laser
ablation (Fig. 4). Further experiments are necessary to confirm
this idea.
The present study was subject to several limitations. First,
the small number in each group limits interpretation of the
results. Second, we were unable to determine the mechanism
of stronger flap adhesion after FS laser flap creation. Therefore,
further studies using larger groups, immunohistochemical
staining, and longer follow-ups are necessary to clarify the
relationship between strong flap adhesion and FS laser use.
Third, in this study, postoperative steroid therapy was not
used. Prednisolone acetate (1%)-treated cornea had less
wound-healing effect in a feline cataract incision than un-
treated or nonsteroidal anti-inflammatory drug (NSAID)-treated
cornea, because this cornea wound had less fibroblastic re-
sponse.31 However, further study is needed to evaluate
whether topical prednisolone acetate 1% can change the ad-
hesion strength of corneal flap in our rabbit model. Fourth,
there were high standard errors in the number of TUNEL-
positive cells around the flap in the FS laser and MM groups.
These errors could be due to artifacts, in that in addition to
keratocytes, other cells present could undergo apoptosis, and
in some cases necrotic cells would be labeled with the TUNEL
assay.32
In conclusion, in this rabbit model, an FS laser produced
greater corneal stromal inflammation early after surgery than
an MM, without any later postoperative increase in apoptosis,
and flap adhesion was stronger. Therefore, the use of the FS
laser method may necessitate the postoperative use of stronger
NSAIDs.
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